Transcatheter Embolization And Occlusion Devices Market Expansion: Projected to Hit $7.87Billion with 10.5% CAGR by 2029

 What is the current market size and future outlook for the transcatheter embolization and occlusion devices market?

The transcatheter embolization and occlusion devices market size has grown rapidly in recent years. It will grow from $4.76 billion in 2024 to $5.28 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to an increase in the target patient population base, a rising number of minimally invasive vascular surgeries, increasing cases of vascular diseases, an increase in chronic disease cases, and the need for effective treatment options.

The transcatheter embolization and occlusion devices market size is expected to see rapid growth in the next few years. It will grow to $7.87 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing research and development activities, an increase in the healthcare sector, growing minimally invasive techniques, an increase in the older population, and an increase in workshops and awareness among people. Major trends in the forecast period include technological advancements, advancements in imaging, integration of artificial intelligence and machine learning, continuous improvements in device design, and advancement in delivery systems.



Get Your Free Sample of The Global Transcatheter Embolization And Occlusion Devices Market Report:
Transcatheter Embolization And Occlusion Devices Market Size Report 2025 And Opportunities Sample

How has the transcatheter embolization and occlusion devices market evolved, and what factors have shaped its growth?

The growing demand for minimally invasive techniques is expected to propel the growth of the transcatheter embolization and occlusion devices market going forward. Minimally invasive surgeries refer to surgical approaches that use small incisions or natural body openings to access and treat internal structures, organs, or tissues to minimize trauma to the patient's body. Transcatheter embolization and occlusion devices are integral to minimally invasive techniques, offering numerous benefits such as reduced invasiveness, shorter recovery times, localized treatment, less pain, lower risk of complications, and the potential for outpatient procedures. For instance, in January 2023, according to Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive care products, in 2022, approximately 1,875,000 surgical procedures were performed with Vinci surgical systems, an increase of roughly 18% compared with approximately 1,594,000 surgical procedures performed in 2021. Therefore, the growing demand for minimally invasive techniques drives the growth of the transcatheter embolization and occlusion devices market.

What are the major segments of the transcatheter embolization and occlusion devices market?
The transcatheter embolization and occlusion devices market covered in this report is segmented –

1) By Type: Coil, Non-Coil
2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users

Subsegments:
1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil
2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles

Order your report now for swift delivery
Transcatheter Embolization And Occlusion Devices Market Size Report 2025 And Opportunities

Which companies dominate the transcatheter embolization and occlusion devices market?

Major companies operating in the transcatheter embolization and occlusion devices market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., AtriCure Inc., Nordion Inc., Sirtex Medical Limited, Cordis Corporation, OpSens Inc., pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc.

How will evolving trends contribute to the growth of the transcatheter embolization and occlusion devices market?

Major companies operating in the transcatheter embolization and occlusion devices market are developing technologically advanced products with functionality, such as multi-catheter compatibility, to serve customers with advanced features better and gain a competitive edge in the market. Multi-catheter compatibility is a feature that can be used with various types of catheters during interventional procedures to offer healthcare providers greater versatility and efficiency in performing transcatheter embolization and occlusion procedures. For instance, in April 2022, Boston Scientific, a US-based medical products company, received FDA clearance for its EMBOLD Fibered Detachable Coil, designed for embolization procedures in the peripheral vasculature. This device is part of the interventional oncology portfolio. It aims to obstruct or reduce blood flow in targeted vessels, addressing conditions such as hemorrhaging, aneurysms, tumor reduction, and venous abnormalities. It features multi-catheter compatibility and a nitinol delivery system to prevent kinks. The coil streamlines procedures reduces potential complications and enhances efficiency.

What are the key regional dynamics of the transcatheter embolization and occlusion devices market, and which region leads in market share?

North America was the largest region in the transcatheter embolization and occlusion devices market in 2024. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Does The Transcatheter Embolization And Occlusion Devices Market Report 2025 Offer?

The transcatheter embolization and occlusion devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Transcatheter Embolization and Occlusion Devices are medical tools used in minimally invasive procedures to block blood flow in specific areas of the body. These devices are delivered through a catheter, which is a thin, flexible tube inserted into the vascular system. The primary goal of these procedures is to treat or manage various medical conditions by obstructing the blood supply to certain tissues or organs.

Purchase the exclusive report now to unlock valuable market insights:
Transcatheter Embolization And Occlusion Devices Market Size Report 2025 And Opportunities

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: Growth Opportunities and Trends in the Rotary Drilling Rig Market: Key Insights for 2025-2034 - Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports - By The Business Research Company
Global Market Model: Global Market Intelligence Database